Search results for "PULMONARY"

showing 10 items of 3030 documents

2014

Background In models of COPD, environmental stressors induce innate immune responses, inflammasome activation and inflammation. However, the interaction between these responses and their role in driving pulmonary inflammation in stable COPD is unknown. Objectives To investigate the activation of innate immunity and inflammasome pathways in the bronchial mucosa and bronchoalveolar lavage (BAL) of patients with stable COPD of different severity and control healthy smokers and non-smokers. Methods Innate immune mediators (interleukin (IL)-6, IL-7, IL-10, IL-27, IL-37, thymic stromal lymphopoietin (TSLP), interferon γ and their receptors, STAT1 and pSTAT1) and inflammasome components (NLRP3, NA…

Pulmonary and Respiratory MedicineCOPDThymic stromal lymphopoietinInnate immune systemmedicine.diagnostic_testbiologybusiness.industryCaspase 1NALP3InflammationInflammasomemedicine.diseaserespiratory tract diseases3. Good healthBronchoalveolar lavageImmunologymedicinebiology.proteinmedicine.symptombusinessmedicine.drugThorax
researchProduct

Ventilación asistida vía máscara nasal en pacientes hospitalizados en una sala de neumología por descompensación de su obstrucción crónica al flujo a…

1995

Our aim was to evaluate the efficacy of assisted ventilation through a nasal mask (AVN) in treating chronic obstructive pulmonary disease (COPD) patients who were admitted to a pneumology ward due to decompensation, with PaCO2 > 60 mmHg and pH < 7.35. We studied 13 COPD patients who were first observed for 1-2 days until adaptation and then given 2 daily sessions of AVN lasting 4 hours with double positive pressure (DP90) devices through Sullivan mask with a cannula for hyperoxia. Gasometric readings were recorded, along with subjective assessment of condition and problems with the mask. Gasometric readings were taken as follows: the first upon admission to the ward (AW), the second with AV…

Pulmonary and Respiratory MedicineCOPDbusiness.industryPulmonary diseasemedicine.diseaseTachypneaCannulaNasal maskMouth openingAnesthesiamedicineDecompensationStatistical analysismedicine.symptombusinessArchivos de Bronconeumología
researchProduct

Palliative Care Needs and Integration of Palliative Care Support in COPD

2021

Background The provision of palliative care for severe COPD remains low, resulting in unmet needs in patients and carers. Research Questions What are the palliative care needs of patients living with severe COPD and their caregivers? What views of accessing and providing palliative care and factors influence these experiences. To what extent have palliative care and COPD services been integrated? Study Design and Methods A multicentre qualitative study was undertaken in COPD services and specialist palliative care in the United Kingdom involving patients with severe COPD, their carers, and health professionals. Data were collected using semistructured interviews and were analyzed using fram…

Pulmonary and Respiratory MedicineCOPDeducation.field_of_studyPalliative careConstant comparisonbusiness.industryData synthesisPopulationCritical Care and Intensive Care Medicinemedicine.disease3. Good healthUnmet needs03 medical and health sciences0302 clinical medicine030228 respiratory systemNursingNeeds assessmentmedicine030212 general & internal medicineCardiology and Cardiovascular MedicineeducationbusinessQualitative researchChest
researchProduct

Paired Inspiratory/Expiratory Volumetric Thin-Slice CT Scan for Emphysema Analysis

2005

Purpose: The aim of the study was to use three-dimensional high-resolution CT scan data sets in inspiration and expiration for the quantitative evaluation of emphysema. Using an advanced dedicated semiautomatic analysis tool, the functional inspiratory/expiratory shifts of emphysema volume and clusters were quantified. The pulmonary function test (PFT) served as the clinical “gold standard.” Materials and methods: Thirty-one patients (9 women and 22 men; mean [± SD] age, 60 ± 8 years) who had severe emphysema due to COPD (Global Initiative for Chronic Obstructive Lung Disease [GOLD] class III and IV) were included in the study. All patients underwent paired inspiratory/expiratory multidetec…

Pulmonary and Respiratory MedicineCOPDmedicine.medical_specialtyInhalationbusiness.industryExhalationrespiratory systemCritical Care and Intensive Care Medicinemedicine.diseaseObstructive lung diseaserespiratory tract diseasesPulmonary function testingMedicineLung volumesLung emphysemaExpirationRadiologyCardiology and Cardiovascular MedicinebusinessNuclear medicineChest
researchProduct

Studienendpunkte bei der chronisch-obstruktiven Lungenerkrankung (COPD): „Minimal Clinically Important Difference”

2008

The concept of the minimal clinically important difference (MCID) is intended to provide a measure of relevance for a statistically applied in patients with COPD. Clinically important differences are those differences relevant to the individual patient and important to the patient's life. However, people's difference in a diagnostic parameter perception of what is important vary. Furthermore, physicians may rate the significance of a particular marker and its difference which can be achieved by a pharmacological intervention differently from the patient. Thus, the major problem with defining an MCID for any measure is that the most important differences, which require the most subtle measur…

Pulmonary and Respiratory MedicineCOPDmedicine.medical_specialtyPathologybusiness.industryMinimal clinically important difference610 Medicine & healthmedicine.diseaseTreatment failureTreatment success2740 Pulmonary and Respiratory MedicineIntervention (counseling)medicineIn patientClinical significance10029 Clinic and Policlinic for Internal MedicineIntensive care medicinebusinessPneumologie
researchProduct

ONCE-DAILY INDACATEROL PROVIDES SUPERIOR BRONCHODILATION, HEALTH STATUS AND CLINICAL OUTCOMES COMPARED WITH SALMETEROL IN PATIENTS WITH CHRONIC OBSTR…

2009

Pulmonary and Respiratory MedicineCOPDmedicine.medical_specialtybusiness.industryTreatment outcomePlacebo-controlled studyCritical Care and Intensive Care Medicinemedicine.diseaseInternal medicineBronchodilationmedicineIndacaterolIn patientSalmeterolOnce dailyCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

β-Blockers in COPD

2018

Background Cardiovascular disease is a frequent comorbidity in patients with COPD. Many physicians, particularly pulmonologists, are reluctant to use β-adrenoceptor blocking agents (β-blockers) in patients with COPD, despite their proven effectiveness in preventing cardiovascular events. Methods The large (5,162 patients) phase III TONADO 1 and 2 studies assessed lung function and patient-reported outcomes in patients with moderate to very severe COPD receiving long-acting bronchodilator treatment across 1 year. This post hoc analysis characterized lung-function changes, patient-reported outcomes, and safety in the subgroup of patients receiving β-blockers in the studies. Results In total, …

Pulmonary and Respiratory MedicineCOPDmedicine.medical_specialtybusiness.industrymedicine.drug_classOlodaterol030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicinemedicine.diseaseComorbidityrespiratory tract diseases03 medical and health sciencesFEV1/FVC ratiochemistry.chemical_compound0302 clinical medicine030228 respiratory systemchemistryBronchodilatorInternal medicineCohortPost-hoc analysismedicineCardiology and Cardiovascular MedicinebusinessCohort studyChest
researchProduct

Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave.

2022

SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.

Pulmonary and Respiratory MedicineCOVID-19 Health-care management Respiratory symptoms Severe asthmasevere asthmamedicine.medical_specialtyTelemedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioPhase (combat)ArticlePandemicmedicineAsthmatic patientHumansPharmacology (medical)Intensive care medicinehealth-care managementPandemicsbusiness.industrySARS-CoV-2Biochemistry (medical)Patient contactrespiratory symptomsCOVID-19AsthmaCommunicable Disease ControlbusinessPulmonary pharmacologytherapeutics
researchProduct

Twenty-year follow-up of children with obstructive sleep apnea.

2022

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) in children is associated with acute metabolic, cardiovascular, and neurocognitive abnormalities. The long-term outcomes of childhood OSA into adulthood have not been established. We performed a 20-year follow-up of patients with polysomnography-documented OSA in childhood compared to a healthy control group to evaluate the long-term anthropometric, sleep, cognitive, and cardiovascular outcomes. METHODS: Children diagnosed with severe OSA between ages 1 and 17 years (mean, 4.87 ± 2.77) were prospectively contacted by telephone as young adults after approximately 20 years. Data collected included reported anthropometric information, educational…

Pulmonary and Respiratory MedicineCOVID-19 children obstructive sleep apnea sleep-disordered breathingAdultSleep Apnea ObstructiveAdolescentPolysomnographysleep-disordered breathingSnoringCOVID-19InfantScientific Investigationsnervous system diseasesrespiratory tract diseasesNeurologychildrenChild PreschoolHumansNeurology (clinical)Childobstructive sleep apneaFollow-Up StudiesJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
researchProduct

Performance of helmet CPAP using different configurations: Turbine-driven ventilators vs Venturi devices

2023

Background Traditionally, Venturi-based flow generators have been preferred over mechanical ventilators to provide continuous positive airway pressure (CPAP) through the helmet (h-CPAP). Recently, modern turbine-driven ventilators (TDVs) showed to be safe and effective in delivering h-CPAP. We aimed to compare the pressure stability during h-CPAP delivered by Venturi devices and TDVs and assess the impact of High Efficiency Particulate Air (HEPA) filters on their performance. Methods We performed a bench study using an artificial lung simulator set in a restrictive respiratory condition, simulating two different levels of patient effort (high and low) with and without the interposition of t…

Pulmonary and Respiratory MedicineCPAP
researchProduct